Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 10Cardiotoxicity 2Trastuzumab Cardiotoxicity 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Neoplasms 1Lymphoma, Non-Hodgkin 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hereditary Breast and Ovarian Cancer Syndrome 1Heart Diseases 1Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6atezolizumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Exercise Test × Breast × Clear all
NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡